publication venue for
- The Role of Statin Therapy for Primary Prevention: What is the Evidence? 2012
- Complex "cross talk" involving nitric oxide metabolites: who's listening?. 8. 2006
- Role of nitrogen oxides on eicosanoid production during atherosclerosis: understanding the controversies.. 3. 2001
- Why Weight? An Analytic Review of Obesity Management, Diabetes Prevention, and Cardiovascular Risk Reduction. 2018
- Imaging to Assess Ischemic Heart Disease in Women. 2018
- New-Generation Coronary Stents: Current Data and Future Directions. 2017
- Novel Anti-glycemic Drugs and Reduction of Cardiovascular Risk in Diabetes: Expectations Realized, Promises Unmet. 2016
- Speciated High-Density Lipoprotein Biogenesis and Functionality. 2016
- Statin Intolerance: the Clinician's Perspective. 2015
- Continuation of Dual-Antiplatelet Therapy Following Percutaneous Revascularization with a Drug-Eluting Stent: What Duration Is Optimal? 2015
- Prostanoids and NSAIDs in cardiovascular biology and disease. 2015
- Cardiovascular prevention in the cancer survivor. 2015
- Role of novel anticoagulants for patients with mechanical heart valves. 2014
- A look at statin cost-effectiveness in view of the 2013 ACC/AHA cholesterol management guidelines. 2014
- Stroke and obstructive sleep apnea: a review. 2013
- MicroRNAs in cardiometabolic disease. 2011
- Evidence for aggressive blood pressure-lowering goals in patients with coronary artery disease. 2010
- Decompressive craniectomy as a therapeutic option in the treatment of hemispheric stroke. 2005
- Randomized clinical stroke trials in 2004. 2005
- Robotics and other devices in the treatment of patients recovering from stroke. 2004
- Cardiovascular implications of HIV-associated dyslipidemic lipodystrophy. 2004
- Cell physiology as a variable in gene transfer to endothelium. 2003
- Alcohol: lipid metabolism and cardioprotection. 2002
- Atherogenesis and the arginine hypothesis. 2001
- Stress echocardiography in the diagnosis of coronary artery disease. 2001
- New concepts in fibrinolysis and angiogenesis. 2000
- Incorporation of low-density lipoprotein apheresis into the treatment program of patients with severe hypercholesterolemia. 2000
- Implications of Bias in Artificial Intelligence: Considerations for Cardiovascular Imaging. 2024
- Free Cholesterol Bioavailability and Atherosclerosis. 2022
- AIBP, Angiogenesis, Hematopoiesis, and Atherogenesis. 2020
- Diagnostic Error in Stroke-Reasons and Proposed Solutions. 2018
- Is Obesity the New Hypertension? Parallels in the Evolution of Obesity and Hypertension as Recognized Disease States. 2017
- Pharmacologic Approaches to Weight Management: Recent Gains and Shortfalls in Combating Obesity. 2016
- Metformin: an Old Therapy that Deserves a New Indication for the Treatment of Obesity. 2016
- Clinical Management of Type 2 Diabetes Mellitus after Bariatric Surgery. 2015
- Cardiometabolic impact of non-statin lipid lowering therapies. 2014
- Detection of atrial fibrillation and secondary stroke prevention using telemetry and ambulatory cardiac monitoring. 2011
- Rimonabant: new data and emerging experience. 2008
- Pharmacotherapy for obesity. 2007
- The ligand/RAGE axis: lighting the fuse and igniting vascular stress. 2006
- Atherosclerosis and inflammation. 2002
- Myocardial hibernation in coronary artery disease. 2002
- The renin angiotensin system as a risk factor for coronary artery disease. 2001